Trial Profile
A Randomized, Parallel Group, Dose-Ranging, Controlled, Multi-Center Study to Assess the Efficacy and Safety of Nexagon in the Treatment of Subjects With a Venous Leg Ulcer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Jul 2018
Price :
$35
*
At a glance
- Drugs Lufepirsen (Primary)
- Indications Leg ulcer
- Focus Therapeutic Use
- Acronyms NOVEL2
- Sponsors OcuNexus Therapeutics
- 25 Jul 2018 According to Ocunexus Therapeutics website, CoDa Therapeutics is now called OcuNexus Therapeutics
- 08 Dec 2014 New trial record